About this episode

Dr. Sumida summarizes the findings of his study on the effectiveness of lubiprostone compared to stool softeners in CKD patients.

In this podcast, Dr. Sumida summarizes the main findings from his study on "Comparative Effectiveness of Lubiprostone and Stool Softeners on Risk of Kidney Outcomes in Patients with CKD" on behalf of his coauthors.

People in this episode

Guest: Dr. Sumida

Topics covered

• chronic kidney disease
• lubiprostone
• stool softeners
• kidney outcomes
• comparative effectiveness

Keywords

• CKD
• lubiprostone
• stool softeners
• kidney outcomes
• comparative effectiveness

Mentioned in this episode

Organizations: American Society of Nephrology

Books & works: Comparative Effectiveness of Lubiprostone and Stool Softeners on Risk of Kidney Outcomes in Patients with CKD

More episodes of Clinical Journal of the American Society of Nephrology (CJASN)

• Total Kidney Volume and eGFR in Polycystic Kidney Disease · May 18, 2026 · 4 min
• Long-Term Results of the ILLUMINATE-A Trial of Lumasiran for Primary Hyperoxaluria Type 1 · March 18, 2026 · 4 min
• Finerenone and eGFR Slope · February 26, 2026 · 3 min
• Dynamic Risk Prediction of Deceased Donor Kidney Transplant Failure · February 18, 2026 · 4 min
• Early-Start vs. Late-Start Icodextrin in Pediatric Peritoneal Dialysis Patients · December 18, 2025 · 6 min
• SGLT2 Inhibition and Hospitalizations in Patients with Chronic Kidney Disease · September 30, 2025 · 4 min

Explore listener stats, chart rankings, contacts and more on the Clinical Journal of the American Society of Nephrology (CJASN) podcast page.